InvestorsHub Logo
Followers 6
Posts 863
Boards Moderated 0
Alias Born 09/28/2012

Re: Fred Kadiddlehopper post# 8178

Saturday, 02/10/2024 2:43:41 PM

Saturday, February 10, 2024 2:43:41 PM

Post# of 8596
In November 2022 Horizon made a deal with XERS to develop a SC formulation of Tepezza. On Jan 10th 2024 Amgen made a deal with them described as an exclusive license. Oddly enough, Amgen announced that they are moving to a phase 3 trial but when an analyst asked what technology they are using, they refused to comment on it. It seems that they are definitely using Xers’s technology. Could they be using Halo’s too? Wishful thinking?

In any case, we have one more uncertainty and probably another setback. I did not remember Horizon had an agreement with Xeris. Again, existing partners making deals with competitors is what I find most troubling.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News